Physician profile
Stephen F Conti
NPI 1902806300
$93,826.98
in general payments reported to CMS, 2019-2025
17 companies · $5,591 in 2025
The $5,591 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $13K · 2021: $6,899 · 2022: $17K · 2023: $19K · 2024: $5,879 · 2025: $5,591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $20K · Consulting Fee: $8,500 · Travel and Lodging: $1,410 · Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $19,660.80 |
| Consulting Fee | $8,500.00 |
| Travel and Lodging | $1,409.63 |
| Food and Beverage | $434.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $42,353.77 | 2019-2022 | |
| Extremity Medical | $28,159.00 | 2020-2025 | Io Freedom |
| Zimvie INC. | $9,909.63 | 2023 | |
| Microaire Surgical Instruments LLC | $5,976.92 | 2019-2020 | |
| Smith+Nephew, INC. | $3,802.39 | 2021-2024 | Panta 2, Uni Cp |
| Integra Lifesciences Corporation | $1,000.00 | 2021 | |
| Depuy Synthes Products, INC. | $925.15 | 2019-2023 | |
| Ascension Orthopedics, INC. | $500.00 | 2020 | |
| Stryker Corporation | $351.82 | 2024-2025 | Inbone, Infinity Adaptis, Invision |
| Wright Medical Technology, INC. | $282.48 | 2019 | |
| Zimmer Biomet Holdings, INC. | $198.20 | 2019-2021 | |
| Ortho Solutions INC | $171.79 | 2019-2020 | |
| Paragon 28, INC. | $140.27 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $30.75 | 2024 | Exparel |
| Depuy Synthes Sales INC. | $13.81 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $11.00 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Conti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.